Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
Biological therapies such as gefitinib may interfere with the growth of the tumor cells and
may make the tumor cells more sensitive to radiation therapy. This phase I/II trial is
studying how well giving gefitinib together with radiation therapy works in treating children
with newly diagnosed glioma.